Key Events This Week
27 Apr: Stock surges 3.88% on strong volume
28 Apr: Technical momentum shifts amid mixed indicators
29 Apr: Mojo grade upgraded to Hold on improved technicals and valuation
30 Apr: Valuation shifts signal price attractiveness change

IOL Chemicals & Pharmaceuticals Ltd: Valuation Shifts Signal Price Attractiveness Change
2026-04-30 08:00:10IOL Chemicals & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive category. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a significant alteration in the stock’s price attractiveness relative to its historical averages and peer group. Investors and analysts are now reassessing the company’s market positioning amid these valuation adjustments.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd Upgraded to Hold on Improved Technicals and Valuation
2026-04-29 08:09:38IOL Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook and valuation metrics. Despite a minor dip in share price, the company’s financial performance, promoter confidence, and market-beating returns have contributed to a more balanced investment stance, signalling cautious optimism among analysts.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd Shows Mixed Technical Signals Amid Mildly Bullish Momentum
2026-04-29 08:00:39IOL Chemicals & Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum from sideways to mildly bullish. Despite a day-on-day price decline of 1.59%, the stock’s technical indicators present a nuanced picture, with some suggesting upward potential while others remain cautious. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals
2026-04-28 08:00:59IOL Chemicals & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a strong price gain of 3.88% on 28 Apr 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent price action, technical parameter changes, and what these mean for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news articleIOL Chemicals & Pharmaceuticals Ltd Falls 2.37%: Mixed Signals Shape Weekly Performance
2026-04-26 12:00:04
Key Events This Week
Apr 20: Downgrade to Sell rating announced
Apr 21: Technical momentum shifts to sideways trend
Apr 23: Mildly bullish momentum emerges amid mixed signals
Apr 23: Valuation reclassified as very expensive
Apr 24: Week closes at Rs.89.00 (-2.37%)

IOL Chemicals & Pharmaceuticals Ltd Sees Mildly Bullish Momentum Amid Mixed Technical Signals
2026-04-23 08:00:32IOL Chemicals & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent upgrade in price action, the stock’s technical indicators present a nuanced picture, with some metrics signalling optimism while others suggest caution. This article analyses the latest technical parameters, price movements, and comparative returns to provide a comprehensive view for investors.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd Valuation Shifts Amid Market Outperformance
2026-04-23 08:00:19IOL Chemicals & Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating. This change reflects evolving market perceptions amid strong price performance and sector-wide valuation trends, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks.
Read full news article
IOL Chemicals & Pharmaceuticals Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
2026-04-21 08:25:04IOL Chemicals & Pharmaceuticals Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a reassessment of its technical outlook, valuation metrics, financial trends, and overall quality. Despite recent positive quarterly results and strong promoter confidence, the stock’s technical indicators have softened and valuation concerns have intensified, prompting a cautious stance from analysts.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
10-Apr-2026 | Source : BSESubmission of Newspaper publication
Disclosure Under Regulation 30 - Participation In Saksham Niveshak Campaign
09-Apr-2026 | Source : BSEDisclosure under Regulation 30
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
04-Apr-2026 | Source : BSECompliance Certificate under Regulation 74
Corporate Actions
No Upcoming Board Meetings
IOL Chemicals & Pharmaceuticals Ltd has declared 50% dividend, ex-date: 17 Feb 26
IOL Chemicals & Pharmaceuticals Ltd has announced 2:10 stock split, ex-date: 11 Mar 25
No Bonus history available
No Rights history available






